Founder at Keragon
Used Claude to analyze his cancer scans, blood work, and wearable data; model flagged thymus rebound as likely benign cause of ambiguous PET scan, avoiding unnecessary radiotherapy.
Referenced in coverage
“Used Claude to analyze his cancer scans, blood work, and wearable data; model flagged thymus rebound as likely benign cause of ambiguous PET scan, avoiding unnecessary radiotherapy.”